Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)Efficacy and Safety of HB-1 for Panic Disorder
Phase 2
Recruiting
- Conditions
- Panic DisorderMental Illness
- Interventions
- First Posted Date
- 2024-07-03
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- Honeybrains Biotech LLC
- Target Recruit Count
- 240
- Registration Number
- NCT06483789
- Locations
- 🇦🇺
Paratus Clinical Research Canberra, Canberra, Australian Capital Territory, Australia
🇦🇺Paratus Clinical Research Western Sydney, Blacktown, New South Wales, Australia
🇦🇺Paratus Clinical Research Central Coast, Kanwal, New South Wales, Australia
Safety and Efficacy of HB-1 for Panic Disorder
- First Posted Date
- 2021-10-08
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- Honeybrains Biotech LLC
- Target Recruit Count
- 86
- Registration Number
- NCT05071430
- Locations
- 🇺🇸
Collaborative Neuroscience Research, Garden Grove, California, United States
🇺🇸Lumos Psychiatric Services, San Jose, California, United States
🇺🇸Institute of Living, Hartford, Connecticut, United States
News
No news found